MedPath

A prospective, observational study to assess the functional recovery, duration of hospital stay, and complications in patients undergoing Robot assisted Uni-compartmental Knee Replacement surgery

Not Applicable
Conditions
Health Condition 1: M179- Osteoarthritis of knee, unspecified
Registration Number
CTRI/2020/11/029048
Lead Sponsor
Anup Institute of Orthopedics and Rehabilitation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients with unicondylar arthritis eligible for Uni-compartmental knee arthroplasty.

2.Male and female aged 45 years and above

3.Subject is willing to take part in the study by signing Ethics Committee (EC) approved informed consent form (ICF)

4.Subjects agrees to comply with postoperative scheduled clinical and radiographic evaluation

Exclusion Criteria

1.Patient with an active infection within the affected knee joint

2.Patient with neuromuscular or neurosensory deficiency that may affect the ability to evaluate the study end points.

3.Patients who are known drug or alcohol abusers or with psychological disorders that could affect follow up care or treatment outcomes.

4.Patients with history of deep vein thrombosis or other thrombotic disorders.

5.Patients with Inflammatory arthropathy, Previous High tibial osteotomy (HTO) with overcorrection, Cruciate ligament lesion, Medial or lateral subluxation (usually associated with a torn ACL), Tibial or femoral shaft deformity, Flexion contracture greater than 15°, Varus deformity greater than 15° (medial UKA), Valgus deformity greater than 20° (lateral UKA), Flexion less than 110°, patellofemoral joint arthritis, obesity, chondrocalcinosis, and crystalline arthropathy

6.Clinical signs of a coexisting severe acute systemic illness (Pneumonia, sepsis, UTI, other co-morbidities)

7.Diagnosis of immune deficiency (AIDS, other congenital

immunodeficiency syndrome, drug therapy with steroids, anticancer drugs etc.)

8.Participation in another clinical study within 30 days before the beginning or anytime during the duration of the current clinical study.

9.Patient is unlikely to adhere to study procedures, keep appointments, or is planning to relocate during the study.

10.Any other reason that in the opinion of the investigator may interfere with the evaluation required by the study.

11.Patient identified as employee of the Investigator or study center as well as family members (i.e. immediate, husband, wife and their children, adopted or natural) of the employees or the Investigator

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To observe the functional recovery, duration of hospital stay and complications of Robotic assisted technology in patients undergoing UKA.Timepoint: Baseline, 5 days post surgery, 6 weeks, 3 and 6 months, 1 year, 2 year, 3 year and 5 year
Secondary Outcome Measures
NameTimeMethod
Changes in pain levels as reported by patients between pre-operation and post-operation during the course of the study (before discharge and post-surgery <br/ ><br>Total time taken for surgery <br/ ><br>Amount of blood loss during surgery <br/ ><br>Bone measurements- Anthropometry, Post bone cut extension gap difference in Minimally invasive surgery. <br/ ><br>Patients requiring spinal vs general anesthesia <br/ ><br>Patients diagnosed with Deep vein thrombosis <br/ ><br>Patients with infections despite Antibiotic prophylaxis <br/ ><br>Implant defects <br/ ><br>Timepoint: one, two, three and five years
© Copyright 2025. All Rights Reserved by MedPath